We have data on 95 companies that use CareFusion Alaris. The companies using CareFusion Alaris are most often found in United States and in the Hospital & Health Care industry. CareFusion Alaris is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for CareFusion Alaris usage goes back as far as 7 years.
|Company||St. Vincent Carmel Hospital|
|Company||Children's Hospital of Philadelphia|
|Company||Cardinal Health Inc|
|St. Vincent Carmel Hospital||stvincent.org||United States||200M-1000M||>10000|
|Tower Health||tower-health.co.uk||United Kingdom||1M-10M||10-50|
|Children's Hospital of Philadelphia||chop.edu||United States||>1000M||>10000|
|Eaton Electric||eatonelectrical.com||United States||>1000M||1-10|
|Cardinal Health Inc||cardinalhealth.com||United States||>1000M||>10000|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, CareFusion Alaris has a market share of about 0.1%. Other major and competing products in this category include:
Alaris infusion systems, infusion software, infusion system therapies, and IV therapy sets and accessories can help pharmacy, nursing and other departments address diverse infusion needs. Their comprehensive portfolio also offers platform interoperability across medical devices and HIT systems to help reduce errors, increase efficiency and enhance patient care.
Looking at CareFusion Alaris customers by industry, we find that Hospital & Health Care (73%) is the largest segment.
80% of CareFusion Alaris customers are in United States.
Of all the customers that are using CareFusion Alaris, a majority (63%) are large (>1000 employees), 5% are small (<50 employees) and 23% are medium-sized.
Of all the customers that are using CareFusion Alaris, a majority (64%) are large (>$1000M), 13% are small (<$50M) and 8% are medium-sized.